SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The primary catalyst driving market sentiment is widespread concern over rising Treasury yields, which have recently breached 5% for the first time since 2007, alongside escalating inflationary pressures from elevated oil prices. Traders are closely monitoring the upcoming Federal Reserve policy meeting, with a strong expectation for a rate hike that has fueled significant volatility and bearish sentiment across major indices.

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Forgent Power Solutions is receiving attention following a strong earnings report and guidance, with the community focused on the company's significant order backlog and its role in meeting the surging power infrastructure demand for AI data centers. While some traders are expressing frustration over price volatility and secondary equity offerings, bulls remain focused on the firm's growth potential and institutional ownership.

XPeng, Inc. is a global Physical AI company, dedicated to bringing artificial intelligence into the physical world to reshape future mobility and smart living. The firm developed a full-stack Physical AI architecture spanning Turing AI chips, world foundation models, and highly integrated software and hardware applications. The product portfolios of smart EVs, robotaxis, and humanoid robots, advancing the deployment of Physical AI at scale. It manufacturing, sales, and services, drives continuous technological innovation and fosters an open physical AI ecosystem, making life smarter, safer, and better for users worldwide. The company was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPeng is experiencing significant bearish sentiment driven by concerns over Chinese economic exposure and persistent sell-offs, despite the company's recent expansion of its global footprint and developments in robotics. Traders are closely monitoring upcoming earnings and delivery data, while many express frustration with the stock's long-term downward trend and broader geopolitical tensions affecting Chinese ADRs.

ProShares Trust II - ProShares Ultra VIX Short-Term Futures ETF 1.5x Shares

ProShares Ultra VIX Short-Term Futures ETF

The community is debating the persistent suppression of volatility, with many traders labeling the instrument a manipulated scam that fails to track market fear appropriately. While some speculators anticipate a significant breakout due to geopolitical tensions, inflation, and bond yield concerns, others warn that its structural decay and contango make it a reliable short-term short rather than a viable long-term hedge.

Carnival Corp. Ltd. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corporation Ltd.

Carnival Corp

Carnival Corp (CCL) is trending as investors react to a Wells Fargo price target reduction, citing concerns over Caribbean cruise pricing pressures, while the community remains divided between bullish long-term growth sentiment and frustration over the stock's recent decline.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is experiencing increased attention as investors track its late-stage clinical progress and potential for ivonescimab to challenge existing standards of care, with the community closely monitoring an upcoming FDA PDUFA date. Sentiment remains driven by recent survival data readouts, significant insider accumulation, and ongoing debate regarding the company's competitive positioning against industry incumbents.

Clover Health Investments Corp. is a physician enablement technology company, which engages in the provision of Medicare Advantage plans in the United States. Its strategy is powered by its proprietary software platform, Clover Assistant, which aggregates patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic diseases. The company offers PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. The company was founded by Vivek Garipalli and Andrew Toy on July 17, 2014 and is headquartered in Wilmington, DE.

Clover Health Investments Corp - Ordinary Shares - Class A

Clover Health Investments Corp

Clover Health is trending as traders point to an external Humana job posting that lists the company's Counterpart Health subsidiary as a vendor, fueling speculation of a major partnership ahead of upcoming investor conferences. While excitement is high regarding this potential deal and its impact on Medicare Advantage Star Ratings, some community members express frustration over the company's lack of official press releases.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending as traders speculate on positive guidance updates and upcoming clinical catalysts, specifically the anticipated Phase 2 non-small cell lung cancer trial data. While the stock has seen significant momentum, community sentiment remains focused on institutional accumulation and the potential for the company's solid tumor platform to drive long-term value.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Market sentiment remains bearish as concerns over rising Treasury yields, specifically the 10-year yield briefly crossing the 5% threshold, and elevated oil prices weigh on risk assets ahead of the upcoming Federal Reserve policy meeting. Traders are closely monitoring this volatility alongside industry debates regarding the pace of AI development, with the community expressing uncertainty over whether policymakers will hike rates or keep them steady.

Bank of America Corp. is a bank and financial holding company, which engages in the provision of banking and nonbank financial services. It operates through the following segments: Consumer Banking, Global Wealth and Investment Management (GWIM), Global Banking, Global Markets, and All Other. The Consumer Banking segment offers credit, banking, and investment products and services to consumers and small businesses. The GWIM segment focuses on solutions to meet clients’ needs through a full set of investment management, brokerage, banking, and retirement products. The Global Banking segment deals with lending-related products and services, integrated working capital management and treasury solutions to clients, and underwriting and advisory services. The Global Markets segment includes sales and trading services, as well as research, to institutional clients across fixed-income, credit, currency, commodity, and equity businesses. The All Other segment consists of asset and liability management activities, equity investments, non-core mortgage loans and servicing activities, the net impact of periodic revisions to the mortgage servicing rights valuation model for both core and non-core MSRs, other liquidating businesses, residual expense allocations and other. The company was founded by Amadeo Peter Giannini in 1904 and is headquartered in Charlotte, NC.

Bank Of America Corp.

Bank of America Corp

Bank of America shares tumbled following CEO Brian Moynihan's comments at a financial conference, where he warned of a double-digit decline in third-quarter investment banking fees and projected flat sales and trading revenue. Traders reacted to the cooling capital-markets outlook with heavy selling, triggering a broad decline across the financial sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$AMC

BOOM!!!!!!!!!!!!!

AMC is about to have its 
BEST YEAR OF THE DECADE.

AVENGERS: DOOMSDAY — 
$1.8 - $2 billion

SPIDER-MAN: BRAND NEW DAY — $1.4 billion

THE SUPER MARIO GALAXY MOVIE — $1.3 billion+ 

TOY STORY 5 — $1.1 billion+

MOANA  (2026 live-action) — 
$1.1 billion 

MINIONS 3: MEGA MINIONS — $900 million – $1.1 billion

DUNE: Part Three (aka Dune: Messiah) — $900 million–$1.2 billion

THE MANDALORIAN &amp; GROGU — $900 million–$1.2 billion

THE ODYSSEY — 
$800 million–$1.1 billion

JUMANJI 3 — 
$800 million - 
$1 billion

SUPERGIRL: WOMAN of TOMORROW — 
$700 million–$900 million

THE HUNGER GAMES: SUNRISE on the REAPING — 
$600 million–$800 million

DISCLOSURE DAY (Spielberg UFO film) — $600 million–$800 million

MICHAEL (biopic) — 
$600 million–$800 million

Blaster666

Amos Quiles

StockTwits For Android 

AMC Entertainment Holdings



BOOM!!!!!!!!!!!!!

AMC is about to have its 
BEST YEAR OF THE DECADE.

AVENGERS: DOOMSDAY — 
$1.8 - $2 billion

SPIDER-MAN: BRAND NEW DAY — $1.4 billion

THE SUPER MARIO GALAXY MOVIE — $1.3 billion+ 

TOY STORY 5 — $1.1 billion+

MOANA  (2026 live-action) — 
$1.1 billion 

MINIONS 3: MEGA MINIONS — $900 million – $1.1 billion

DUNE: Part Three (aka Dune: Messiah) — $900 million–$1.2 billion

THE MANDALORIAN & GROGU — $900 million–$1.2 billion

THE ODYSSEY — 
$800 million–$1.1 billion

JUMANJI 3 — 
$800 million - 
$1 billion

SUPERGIRL: WOMAN of TOMORROW — 
$700 million–$900 million

THE HUNGER GAMES: SUNRISE on the REAPING — 
$600 million–$800 million

DISCLOSURE DAY (Spielberg UFO film) — $600 million–$800 million

MICHAEL (biopic) — 
$600 million–$800 million